• Channels
    • All News
    • Premium Stories
    • R&D
    • Pharma
    • Venture
    • People
    • Startups
    • Regulatory
    • Deals
    • IPOs
    • China
    • Cell/Gene Tx
    • Bioregnum
    • Peer Review
    • Discovery
    • Outsourcing
    • AI
    • Special
  • Events
  • Biopharma Jobs
  • More
    • Webinars
    • Sponsored Posts
    • Biotech Voices
    • Advertise
    • Privacy Policy
    • About Us
    • Help
  • SUBSCRIBE

Aca­dia de­clares ear­ly win on Nu­plazid de­men­tia study, stun­ning an­a­lysts and send­ing shares soar­ing

3 months ago
Pharma
R&D

Tony Coles sets sail on new neu­ro pur­suit at Cerev­el, steer­ing Pfiz­er spin­out as CEO

3 months ago
People

Eli Lil­ly hus­tles up an im­pres­sive set of piv­otal da­ta for their $8B Loxo drug — as ri­val nips at their heels

3 months ago
R&D

MIT’s star tech gu­ru Joi Ito re­signs biotech chair post in wake of Jef­frey Ep­stein scan­dal

3 months ago
People

A strong per­for­mance by AMG510 stokes fresh en­thu­si­asm on the fu­ture of Am­gen's land­mark KRAS G12C pro­gram — but shares slide

3 months ago
R&D

Genen­tech reach­es set­tle­ment with Tai­wanese biotech ac­cused of steal­ing trade se­crets — but will keep su­ing ex-staffers

3 months ago
Pharma

Roivan­t's Vivek Ra­maswamy is clos­ing in on a $3B cash deal to sell con­trol of 5 Vants — plus — to Sum­it­o­mo Dainip­pon

3 months ago
Deals
People

How much has the can­cer R&D fren­zy trans­lat­ed in­to drug ap­provals? A lot

3 months ago
R&D
Regulatory

The IFM team sets up a three-peat as No­var­tis funds cGAS/STING pro­gram — with $840M op­tion to buy

3 months ago
Deals
R&D

The phar­ma in­dus­try's rep hits ab­solute. rock. bot­tom.

3 months ago
Pharma

Ex-FDA chiefs, non-prof­its take Ned Sharp­less' cor­ner as clock ticks down on Trump's pick

3 months ago
R&D

George Scan­gos heads back to Wall Street. And he’s bring­ing along some of the best con­nec­tions in biotech

3 months ago
IPOs

In the midst of a deal spree, Bay­er turns to vet­er­an J&J deal­mak­er Mar­i­anne De Backer to bring home the tech­nol­o­gy

3 months ago
People

Arde­lyx's lead drug tena­panor scores in sec­ond hy­per­phos­phatemia study, shares leap

3 months ago
R&D

Ver­tex gam­bles $950M on biotech buy­out, hunt­ing a cure for di­a­betes

3 months ago
Deals
R&D

RA Cap­i­tal-backed cell ther­a­py play­er in the neoanti­gen game grabs a $121M megaround to fund first hu­man stud­ies

3 months ago
Startups
Venture

A new PC­SK9 play­er draws rave re­views for in­clisir­an. Can a mar­ket­ing war with Am­gen be far be­hind?

3 months ago
Pharma
R&D

Alex­ion hit by sur­prise in­ter partes re­view as Am­gen chal­lenges Soliris patents

3 months ago
Pharma

Re­mem­ber that post-mar­ket­ing tri­al? New study con­firms many drug­mak­ers don’t do them — half drag their feet

3 months ago
Bioregnum

No­var­tis preps a 2020 launch in mul­ti­ple scle­ro­sis as 2 suc­cess­ful piv­otal tri­als set stage for an as­sault on Roche’s new star fran­chise

3 months ago
Pharma
R&D

Ab­b­Vie’s $10B Ro­va-T play ends in one last fail­ure — R&D team shuts it all down

3 months ago
R&D

Am­gen’s leg­endary lawyer corps los­es a ma­jor court fight at­tempt­ing to quash PC­SK9 ri­val from Sanofi, Re­gen­eron

3 months ago
Pharma

Tears for FAERS: An­oth­er FAERS dis­as­ter ru­mor slams Ver­tex shares in a Wall Street melee — but this time the tem­pest passed quick­ly

3 months ago
Pharma

The Wood­ford ef­fect: Tee­ter­ing on the edge, his co-in­vestors are feel­ing the pain — and they want it to stop

3 months ago
R&D
First page Previous page 78910111213 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Premium Stories
  • Don't Miss

Channels

  • R&D
  • Pharma
  • Venture
  • People
  • Startups
  • Regulatory
  • Deals
  • IPOs
  • China
  • Cell/Gene Tx
  • Bioregnum
  • Peer Review
  • Discovery
  • Outsourcing
  • AI
  • Special

More

  • Events
  • Webinars
  • Sponsored Posts
  • Biotech Voices
  • Advertise
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© 2019 — Endpoints Company

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
Endpoints News

Sign in to your account

e-mail

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you sign in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

About You

Subscriptions

ENDPOINTS by John Carroll & team — all the news at 11:30a ET

EARLY EDITIONby Arsalan Arif — skimmable links and news at 7:15a ET